Researchers have developed an oral form of insulin that lowers glucose levels in animal models. The oral insulin, encased in a nano-carrier that delivers insulin to the liver, is expected to begin human trials in 2025.
A new test that "fishes" for multiple respiratory viruses at once using single strands of DNA as "bait", and gives highly accurate results in under an hour, has been developed by Cambridge researchers.